Merck

Anura mobile app by NuraLogix
By  Adam Ang 10:50 pm June 2, 2022
NuraLogix introduces health measurement app in Singapore Canadian health AI company NuraLogix has introduced its mobile health measurement app in Singapore. Anura uses proprietary transdermal optical imaging technology, which captures blood information from a person's face through a video camera. It can measure various vital parameters, including blood pressure, heart rate, stress level, cardiac...
Researcher
By  Laura Lovett 02:05 pm February 18, 2022
Artificial intelligence could potentially disrupt nearly every industry. Pharma giants have continued to take note. From AI in drug discovery to digital therapeutics, big name life science companies have invested time and money into the space.  However, big tech's move fast and break things mentality doesn't always align with pharma's regulated model. Today a number of accelerators and labs are...
Healthcare professional in a mask swabs patient arm with cotton before administering a vaccine
By  Mallory Hackett 11:38 am June 11, 2021
A group of organizations across the technology, healthcare, global development and academic sectors are convening on a new initiative that hopes to advance public understanding of how social media and behavioral sciences can be used to improve public health globally. Called the Alliance for Advancing Health Online, the project’s partners include Bay Area Global Health Alliance, the CDC Foundation...
fertility tool, femtech
By  Sara Mageit 06:36 am January 19, 2021
Netherlands-based global health technology company, Royal Philips has announced a multi-year partnership with US science and technology company, Merck to develop digital solutions for personalised fertility treatment. WHY IT MATTERS According to the National Health Service, roughly one in seven couples in the UK will have trouble conceiving. The platform will leverage advanced informatics and...
By  Dean Koh 02:57 am November 11, 2020
Singapore-based data science and healthcare technology company Holmusk announced a collaboration with the Healthcare business sector of German pharma and life sciences giant Merck to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes. The partnership involves Holmusk's GlycoLeap, a mobile digital therapeutics platform that utilizes a...
By  Laura Lovett 03:37 pm January 22, 2020
The skinny on acquisition news. This morning Providence St. Joseph Health announced that it was acquiring weight management program HMR (Health Management Resources) from Merck. The tech-enabled program offers an app with weight loss resources, group phone coaching and in-person classes. Prior to this acquisition three of HMR’s clinics were inside of Providence facilities, and the organization...
By  Dean Koh 10:09 pm December 9, 2019
Last week, Ping An Good Doctor, China’s one-stop healthcare ecosystem platform signed a strategic collaboration with Merck, a German multinational pharmaceutical, chemical and life sciences company to jointly explore integrated solutions to advance intelligent healthcare in China. According to the joint media release, the collaboration will leverage Ping An Good Doctor's extensive experience in...
By  Dave Muoio 11:20 am November 6, 2019
Boston-based PathAI, maker of artificial intelligence tools for pathology, has capped off its Series B funding round with a $15 million strategic investment from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. This raise brings the startup’s full round to $75 million, and its total funding to just over $90 million. WHAT THEY DO PathAI’s platform employs convolutional neural...
By  Dean Koh 12:18 am January 24, 2019
Yesterday, Merck, a German multinational pharmaceutical, chemical and life sciences company, and Tencent, a Chinese multinational investment holding conglomerate, signed a strategic collaboration agreement. The collaboration will primarily focus on increasing public disease awareness and providing more accessible healthcare services via digital platforms in China. “In this collaboration with...
By  Jonah Comstock 05:44 am November 7, 2018
By and large, Q3 2018 was a slow and steady quarter for pharma moves in digital health, at least in terms of publicly disclosed operations. At events during the quarter, the likes of Johnson & Johnson, AstraZeneca, Novartis and Sanofi discussed digital therapeutics and expressed a healthy mixture of skepticism and enthusiasm for the space. “These technologies have a tremendous opportunity to...